| EXEL YTD Return Table | ||||||||||||||||||||||||||||||
EXEL YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare EXEL YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| EXEL Share Performance |
| EXEL YTD Return Chart | |||
Also see: EXEL Average Annual Return | |||
| About Exelixis Inc |
| Exelixis, Inc. is an oncology company. Co. is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma (RCC), for previously treated hepatocellular carcinoma (HCC) and for previously treated, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). The EXEL YTD return is shown above.
The YTD Return on the EXEL YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether EXEL YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the EXEL YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| EXEL Current Stock Quote |
 Free EXEL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Exelixis (EXEL) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
EYE YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.
Video: Don't Forget Dividends in YTD Return!